The Aidaptus ® disposable auto-injector platform, designed by Owen Mumford, will be jointly offered to global biopharma companies to support their drug development programs with engineering and ...

Stevanato has added another drug delivery technology to its portfolio, teaming up with Owen Mumford to provide customers with a two-step, single-use auto-injector that automatically adapts to a range ...

Franco Stevanato, CEO, Stevanato Group: We are putting, David, a lot of attention in these therapeutic drugs because in this moment, in parallel with our originator, our biosimilar clients, we are ...

On Wednesday, 19 November 2025, Stevanato Group (NYSE:STVN) presented at the Jefferies London Healthcare Conference 2025, showcasing its strategic vision for growth in the pharmaceutical industry. The ...